{"id":1215,"date":"2026-11-19T09:36:08","date_gmt":"2026-11-19T09:36:08","guid":{"rendered":"https:\/\/theapnachhattisgarh.com\/?p=1215"},"modified":"2026-11-19T09:36:08","modified_gmt":"2026-11-19T09:36:08","slug":"centre-proposes-central-approval-for-antimicrobials-amid-amr-concerns-industry-news","status":"publish","type":"post","link":"https:\/\/theapnachhattisgarh.com\/?p=1215","title":{"rendered":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News"},"content":{"rendered":"<p><br \/>\n<\/p>\n<div id=\"parent_top_div\" style=\"margin:0 0\">\n<p>Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight from state licensing authorities to the Central Licensing Authority (CLA).<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Under a draft notification dated November 18 reviewed by Business Standard, antimicrobials are proposed to be added to the definition of \u201cnew drug\u201d under Rule 2 of the New Drugs and Clinical Trials Rules, 2019.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The provision currently covers seven biological and specialised therapeutic product categories \u2014 vaccines, recombinant DNA-derived products, living modified organisms, monoclonal antibodies, stem cell-derived products, gene therapeutic products and xenografts.<\/p>\n<p><span style=\"display:block;height:1px\">\u00a0<\/span><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Antimicrobials are part of the anti-infective therapy segment, which is the third-largest segment by value in the Indian pharmaceutical market (IPM), accounting for around 11 per cent, according to market research firm Pharmarack.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The segment recorded moving annual turnover (MAT), or sales over the preceding 12 months, of Rs 29,219 crore during November 2025-October 2026, up 7.14 per cent from Rs 27,270 crore in the corresponding period a year earlier.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>Officials aware of the matter said the proposed amendment had been initiated amid concerns over manufacturing licences being granted for antimicrobials without adequate regulatory scrutiny, including requirements relating to bioavailability (BA), bioequivalence (BE) and stability studies.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>\u201cThe absence of such assessments may affect the quality, safety and efficacy of antimicrobial products. Substandard or ineffective antimicrobials can contribute to the development and spread of antimicrobial resistance, posing risks to patient safety,\u201d the ministry said on Thursday.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The NDCT framework already lays down requirements for applications seeking permission to import or manufacture new drugs, including pharmaceutical, toxicological and clinical data, while the rules also govern BA and BE studies.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The proposal comes amid growing concern over antimicrobial resistance (AMR), which occurs when bacteria, viruses, fungi and parasites change over time and stop responding adequately to medicines, making infections harder to treat.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>An earlier global estimate cited by the World Health Organization (WHO) warned that drug-resistant diseases could cause 10 million deaths annually by 2050 without adequate action. WHO\u2019s India office has said India could account for about 2 million deaths annually by then.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>More recent estimates have further underlined the scale of the threat. WHO said in 2025 that drug-resistant infections could claim 39 million lives cumulatively by 2050 without stronger intervention.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The draft notification has invited objections and suggestions from stakeholders and members of the public within 30 days of its publication.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The Centre has taken a series of measures aimed at slowing the rise of AMR.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The Union Health Ministry amended the Drugs Rules in January 2026 to require antimicrobials and their preparations to carry a blue vertical strip on their packaging labels.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The move followed a report submitted in November 2025 by a high-level subcommittee of the Central Drugs Standard Control Organisation\u2019s (CDSCO\u2019s) Drugs Consultative Committee (DCC), which outlined a series of recommendations for strengthening India\u2019s response to AMR.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>The Directorate General of Health Services (DGHS) has also asked pharmacies not to dispense antibiotics without a doctor\u2019s prescription amid concerns that medicines such as azithromycin and amoxicillin are commonly sold over the counter.<\/p>\n<p><small class=\"brtag\">\u00a0<\/small><\/p>\n<p>If finalised, the latest proposal would mark a significant shift in the regulation of antimicrobials by bringing their approval under greater central scrutiny and introducing more uniform requirements for evidence on quality, safety and efficacy.\u00a0<\/p>\n<\/div>\n\n","protected":false},"excerpt":{"rendered":"<p>Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional<\/p>\n","protected":false},"author":1,"featured_media":1216,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_newsletter_access":"","_jetpack_dont_email_post_to_subs":false,"_jetpack_newsletter_tier_id":0,"_jetpack_memberships_contains_paywalled_content":false,"_jetpack_hide_featured_image":false,"_jetpack_featured_image_duplicate_dismissed":0,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[],"class_list":["post-1215","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-india"],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.5.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"The Apna Chhattisgarh\"\/>\n\t<link rel=\"canonical\" href=\"https:\/\/theapnachhattisgarh.com\/?p=1215\" \/>\n\t\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.5.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"en_US\" \/>\n\t\t<meta property=\"og:site_name\" content=\"The Apna Chhattisgarh -\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh\" \/>\n\t\t<meta property=\"og:description\" content=\"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/theapnachhattisgarh.com\/?p=1215\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg\" \/>\n\t\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t\t<meta property=\"og:image:height\" content=\"628\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2026-11-19T09:36:08+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2026-11-19T09:36:08+00:00\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#blogposting\",\"name\":\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh\",\"headline\":\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News\",\"author\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg\",\"width\":1200,\"height\":628},\"datePublished\":\"2026-11-19T09:36:08+00:00\",\"dateModified\":\"2026-11-19T09:36:08+00:00\",\"inLanguage\":\"en-US\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#webpage\"},\"articleSection\":\"India\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"name\":\"India\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"position\":2,\"name\":\"India\",\"item\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#listItem\",\"name\":\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#listItem\",\"position\":3,\"name\":\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?cat=21#listItem\",\"name\":\"India\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\",\"name\":\"The Apna Chhattisgarh\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/10\\\/cropped-WhatsApp-Image-2026-10-24-at-10.47.40-PM.jpeg\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215\\\/#organizationLogo\",\"width\":1597,\"height\":362},\"image\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215\\\/#organizationLogo\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1\",\"name\":\"The Apna Chhattisgarh\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/af79d0a817c8720a95b0601916cbb419fbcc63fe5df7fc5a696773013f741e58?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"The Apna Chhattisgarh\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#webpage\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215\",\"name\":\"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh\",\"description\":\"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight\",\"inLanguage\":\"en-US\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?author=1#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/wp-content\\\/uploads\\\/2026\\\/11\\\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215\\\/#mainImage\",\"width\":1200,\"height\":628},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/?p=1215#mainImage\"},\"datePublished\":\"2026-11-19T09:36:08+00:00\",\"dateModified\":\"2026-11-19T09:36:08+00:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#website\",\"url\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/\",\"name\":\"The Apna Chhattisgarh\",\"inLanguage\":\"en-US\",\"publisher\":{\"@id\":\"https:\\\/\\\/theapnachhattisgarh.com\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh","description":"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight","canonical_url":"https:\/\/theapnachhattisgarh.com\/?p=1215","robots":"max-image-preview:large","keywords":"","webmasterTools":{"miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#blogposting","name":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh","headline":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News","author":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"publisher":{"@id":"https:\/\/theapnachhattisgarh.com\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg","width":1200,"height":628},"datePublished":"2026-11-19T09:36:08+00:00","dateModified":"2026-11-19T09:36:08+00:00","inLanguage":"en-US","mainEntityOfPage":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#webpage"},"isPartOf":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#webpage"},"articleSection":"India"},{"@type":"BreadcrumbList","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/#listItem","position":1,"name":"Home","item":"https:\/\/theapnachhattisgarh.com\/","nextItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","name":"India"}},{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","position":2,"name":"India","item":"https:\/\/theapnachhattisgarh.com\/?cat=21","nextItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#listItem","name":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News"},"previousItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#listItem","position":3,"name":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News","previousItem":{"@type":"ListItem","@id":"https:\/\/theapnachhattisgarh.com\/?cat=21#listItem","name":"India"}}]},{"@type":"Organization","@id":"https:\/\/theapnachhattisgarh.com\/#organization","name":"The Apna Chhattisgarh","url":"https:\/\/theapnachhattisgarh.com\/","logo":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/10\/cropped-WhatsApp-Image-2026-10-24-at-10.47.40-PM.jpeg","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215\/#organizationLogo","width":1597,"height":362},"image":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1215\/#organizationLogo"}},{"@type":"Person","@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author","url":"https:\/\/theapnachhattisgarh.com\/?author=1","name":"The Apna Chhattisgarh","image":{"@type":"ImageObject","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/af79d0a817c8720a95b0601916cbb419fbcc63fe5df7fc5a696773013f741e58?s=96&d=mm&r=g","width":96,"height":96,"caption":"The Apna Chhattisgarh"}},{"@type":"WebPage","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#webpage","url":"https:\/\/theapnachhattisgarh.com\/?p=1215","name":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh","description":"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight","inLanguage":"en-US","isPartOf":{"@id":"https:\/\/theapnachhattisgarh.com\/#website"},"breadcrumb":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#breadcrumblist"},"author":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"creator":{"@id":"https:\/\/theapnachhattisgarh.com\/?author=1#author"},"image":{"@type":"ImageObject","url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg","@id":"https:\/\/theapnachhattisgarh.com\/?p=1215\/#mainImage","width":1200,"height":628},"primaryImageOfPage":{"@id":"https:\/\/theapnachhattisgarh.com\/?p=1215#mainImage"},"datePublished":"2026-11-19T09:36:08+00:00","dateModified":"2026-11-19T09:36:08+00:00"},{"@type":"WebSite","@id":"https:\/\/theapnachhattisgarh.com\/#website","url":"https:\/\/theapnachhattisgarh.com\/","name":"The Apna Chhattisgarh","inLanguage":"en-US","publisher":{"@id":"https:\/\/theapnachhattisgarh.com\/#organization"}}]},"og:locale":"en_US","og:site_name":"The Apna Chhattisgarh -","og:type":"article","og:title":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh","og:description":"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight","og:url":"https:\/\/theapnachhattisgarh.com\/?p=1215","og:image":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg","og:image:secure_url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg","og:image:width":1200,"og:image:height":628,"article:published_time":"2026-11-19T09:36:08+00:00","article:modified_time":"2026-11-19T09:36:08+00:00","twitter:card":"summary_large_image","twitter:title":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News - The Apna Chhattisgarh","twitter:description":"Antimicrobials such as antibiotics, antivirals and antifungals may soon come under a stricter central approval framework, with additional clinical, bioavailability, bioequivalence and safety requirements before they can be manufactured or marketed in India. The Union Health Ministry is considering bringing antimicrobials under the New Drugs and Clinical Trials (NDCT) Rules, shifting their regulatory oversight","twitter:image":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg"},"aioseo_meta_data":[],"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/theapnachhattisgarh.com\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/theapnachhattisgarh.com\/?cat=21\" title=\"India\">India<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tCentre proposes central approval for antimicrobials amid AMR concerns | Industry News\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/theapnachhattisgarh.com\/"},{"label":"India","link":"https:\/\/theapnachhattisgarh.com\/?cat=21"},{"label":"Centre proposes central approval for antimicrobials amid AMR concerns | Industry News","link":"https:\/\/theapnachhattisgarh.com\/?p=1215"}],"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/theapnachhattisgarh.com\/wp-content\/uploads\/2026\/11\/1795080566_pharma-drugs-medicine-1784750098-39752030.jpg","_links":{"self":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts\/1215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1215"}],"version-history":[{"count":0,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/posts\/1215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=\/wp\/v2\/media\/1216"}],"wp:attachment":[{"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/theapnachhattisgarh.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}